Neuropsicofarmacología - GIC 21/128
Universitat de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadoras/es de Universitat de Barcelona (55)
2024
-
Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study
European Neuropsychopharmacology, Vol. 85, pp. 66-77
-
Exploring the reactivity of bicyclic α-iminophosphonates to access new imidazoline I2 receptor ligands
Bioorganic Chemistry, Vol. 142
-
NRN1 epistasis with BDNF and CACNA1C: mediation effects on symptom severity through neuroanatomical changes in schizophrenia
Brain Structure and Function, Vol. 229, Núm. 5, pp. 1299-1315
-
Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study
Spanish Journal of Psychiatry and Mental Health
-
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry
Seminars in Arthritis and Rheumatism, Vol. 66
-
The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls
EMBO Molecular Medicine, Vol. 16, Núm. 4, pp. 755-783
2023
-
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases
The Lancet Rheumatology
-
Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism
Neuropsychopharmacology, Vol. 48, Núm. 2, pp. 341-350
-
Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease
Pharmaceutics, Vol. 15, Núm. 10
-
Selective inhibition of cannabinoid CB1 receptor-evoked signalling by the interacting protein GAP43
Neuropharmacology, Vol. 240
2022
-
Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort
Annals of the rheumatic diseases, Vol. 81, Núm. 3, pp. 370-378
-
High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers
International Journal of Neuropsychopharmacology, Vol. 25, Núm. 6, pp. 468-478
-
NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches
International Journal of Molecular Sciences, Vol. 23, Núm. 13
-
Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine
Lupus Science and Medicine, Vol. 9, Núm. 1
-
Saving the kidneys in the lupus patient: Beyond immunosuppression, the need to collaborate across multiple disciplines
European Journal of Internal Medicine, Vol. 99, pp. 19-21
2021
-
Adrenergic Modulation With Photochromic Ligands
Angewandte Chemie - International Edition, Vol. 60, Núm. 7, pp. 3625-3631
-
Benzofuranyl-2-imidazoles as imidazoline I2 receptor ligands for Alzheimer's disease
European Journal of Medicinal Chemistry, Vol. 222
-
Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophrenia
Neuropsychopharmacology, Vol. 46, Núm. 3, pp. 665-672
-
European League against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance
Annals of the Rheumatic Diseases, Vol. 80, Núm. 6, pp. 775-781
-
Identification of bip as a cb1 receptor-interacting protein that fine-tunes cannabinoid signaling in the mouse brain
Journal of Neuroscience, Vol. 41, Núm. 38, pp. 7924-7941